Act | West FY 22 Semi Annual Report: October 2021 - March 2022

This report outlines the key achievements and challenges in the first six months of the fourth year of program implementation, spanning the period October 1, 2021–March 31, 2022.

Semi Annual Report I

Front cover of SAR with 8 photos arranged in a rectangle
Semi-annual report
Year of publication
All Preventive Chemotherapy NTDs
All Countries, Benin, Burkina Faso, Cameroon, Cote d’Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Sierra Leone, Togo
Focus Areas
Mass Drug Administration (MDA), MDA implementation, Community outreach, Drug procurement & supply chain support, Cross-border initiatives, Annual training for MDA, Support for NTD Sustainability, Advocacy and policies, Cross-sector collaboration, NTD governance, Strategic health information, NTD Capacity Building, Monitoring, Evaluation, Research, Learning and Adapting (MERLA), Disease-specific assessments, post-treatment surveillance, and related training, Disease & morbidity mapping & assessment, Learning & quality improvement, Data for decision-making, Operational research, Dossier development
AIM Initiative, Deloitte, FHI360, HDI, Helen Keller International, World Vision